Cytotoxic Effect of Recombinant Mycobacterium tuberculosis CFP-10/ESAT-6 Protein on the Crucial Pathways of WI-38 Cells

被引:9
|
作者
Tsai, Kun-Nan [1 ]
Chan, Err-Cheng [2 ]
Tsai, Tsung-Yeh [1 ]
Chen, Kuei-Tien [2 ]
Chen, Chun-Yu [2 ]
Hung, Kenneth [1 ]
Chen, Chung-Ming [1 ]
机构
[1] Natl Taiwan Univ, Inst Biomed Engn, Taipei 100, Taiwan
[2] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan
来源
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2009年
关键词
KAPPA-B; INTERFERON-GAMMA; EXPRESSION DATA; ESAT-6; COMPLEX; CFP-10; GENES; MACROPHAGES; ONTOLOGIES; SECRETION;
D O I
10.1155/2009/917084
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To unravel the cytotoxic effect of the recombinant CFP-10/ESAT-6 protein (rCFES) on WI-38 cells, an integrative analysis approach, combining time-course microarray data and annotated pathway databases, was proposed with the emphasis on identifying the potentially crucial pathways. The potentially crucial pathways were selected based on a composite criterion characterizing the average significance and topological properties of important genes. The analysis results suggested that the regulatory effect of rCFES was at least involved in cell proliferation, cell motility, cell survival, and metabolisms of WI-38 cells. The survivability of WI-38 cells, in particular, was significantly decreased to 62% with 12.5 mu M rCFES. Furthermore, the focal adhesion pathway was identified as the potentially most-crucial pathway and 58 of 65 important genes in this pathway were downregulated by rCFES treatment. Using qRT-PCR, we have confirmed the changes in the expression levels of LAMA4, PIK3R3, BIRC3, and NFKBIA, suggesting that these proteins may play an essential role in the cytotoxic process in the rCFES-treated WI-38 cells. Copyright (C) 2009 Kun-Nan Tsai et al.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Utility of recombinant fusion protein ESAT6-CFP10 skin test for differential diagnosis of active tuberculosis: A prospective study
    Yuan, Yuan
    Xia, Lu
    Wu, Qiaoyu
    Liu, Xuhui
    Lu, Shuihua
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] A NEW QUANTITATIVE DETECTION METHOD OF RECOMBINANT CFP10-ESAT6 AMALGAMATION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS BASED ON MICRO-MAGNETIC PROBES STRATEGY
    Huang, Yiqing
    Luo, Jinping
    Wang, Mixia
    Liu, Juntao
    Cai, Xinxia
    JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES, 2012, 5 (01)
  • [43] Mycobacterium tuberculosis antigen 85B and ESAT-6 expressed as a recombinant fusion protein in Mycobacterium smegmatis elicits cell-mediated immune response in a murine vaccination model
    Tsolaki, Anthony G.
    Nagy, Judit
    Leiva, Sergio
    Kishore, Uday
    Rosenkrands, Ida
    Robertson, Brian D.
    MOLECULAR IMMUNOLOGY, 2013, 54 (3-4) : 278 - 283
  • [44] Serodiagnosis Efficacy and Immunogenicity of the Fusion Protein of Mycobacterium tuberculosis Composed of the 10-Kilodalton Culture Filtrate Protein, ESAT-6, and the Extracellular Domain Fragment of PPE68
    Xu, Jia-Nan
    Chen, Jian-Ping
    Chen, Da-Li
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (04) : 536 - 544
  • [45] Response of IFN-γ and IgG to ESAT-6 and 38 kDa recombinant proteins and their peptides from Mycobacterium tuberculosis in tuberculosis patients and asymptomatic household contacts may indicate possible early-stage infection in the latter
    López-Vidal, Y
    de León-Rosales, SP
    Castañón-Arreola, M
    Rangel-Frausto, MS
    Meléndez-Herrada, E
    Sada-Díaz, E
    ARCHIVES OF MEDICAL RESEARCH, 2004, 35 (04) : 308 - 317
  • [46] A peptide fragment from the human COX3 protein disrupts association of Mycobacterium tuberculosisvirulence proteins ESAT-6 and CFP10, inhibits mycobacterial growth and mounts protective immune response
    Sachin Kumar Samuchiwal
    Sultan Tousif
    Dhiraj Kumar Singh
    Arun Kumar
    Anamika Ghosh
    Kuhulika Bhalla
    Prem Prakash
    Sushil Kumar
    Maitree Bhattacharyya
    Prashini Moodley
    Gobardhan Das
    Anand Ranganathan
    BMC Infectious Diseases, 14
  • [47] Safety of Recombinant Fusion Protein ESAT6-CFP10 as a Skin Test Reagent for Tuberculosis Diagnosis: an Open-Label, Randomized, Single-Center Phase I Clinical Trial
    Li, Feng
    Xu, Miao
    Zhou, Lijun
    Xiong, Yanqing
    Xia, Lu
    Fan, Xiaoyong
    Gu, Jun
    Pu, Jiang
    Lu, Shuihua
    Wang, Guozhi
    CLINICAL AND VACCINE IMMUNOLOGY, 2016, 23 (09) : 767 - 773
  • [48] Differential Live Mycobacterium tuberculosis-, M-bovis BCG-, Recombinant ESAT6-, and Culture Filtrate Protein 10-Induced Immunity in Tuberculosis
    Hasan, Zahra
    Jamil, Bushra
    Ashraf, Mussarat
    Islam, Muniba
    Dojki, Maqboola
    Irfan, Muhammad
    Hussain, Rabia
    CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (07) : 991 - 998
  • [49] Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70
    Dai, Fu-Ying
    Wang, Jun-Fang
    Gong, Xue-Li
    Bao, Lang
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (06) : 1425 - 1432
  • [50] Mycobacterium tuberculosis–Secreted Protein, ESAT-6, Inhibits Lipopolysaccharide-Induced MMP-9 Expression and Inflammation Through NF-κB and MAPK Signaling in RAW 264.7 Macrophage Cells
    Sun-Hyung Ha
    Hyunju Choi
    Jun-Young Park
    Fukushi Abekura
    Young-Choon Lee
    Jeong-Ran Kim
    Cheorl-Ho Kim
    Inflammation, 2020, 43 : 54 - 65